EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $128,469 | +14.6% | 17,061 | -4.1% | 0.00% | – |
Q2 2022 | $112,121 | -3.8% | 17,797 | +26.8% | 0.00% | – |
Q1 2022 | $116,491 | +94.2% | 14,035 | +21.4% | 0.00% | – |
Q4 2021 | $60,000 | -67.9% | 11,564 | -47.2% | 0.00% | – |
Q2 2021 | $187,000 | +9.4% | 21,902 | +13.1% | 0.00% | – |
Q1 2021 | $171,000 | -31.0% | 19,361 | -4.1% | 0.00% | – |
Q4 2020 | $248,000 | +90.8% | 20,185 | +26.1% | 0.00% | – |
Q3 2020 | $130,000 | -9.7% | 16,002 | +7.4% | 0.00% | – |
Q2 2020 | $144,000 | +29.7% | 14,904 | -8.3% | 0.00% | – |
Q1 2020 | $111,000 | -50.4% | 16,258 | +8.3% | 0.00% | – |
Q4 2019 | $224,000 | +31.8% | 15,008 | -7.2% | 0.00% | – |
Q3 2019 | $170,000 | 0.0% | 16,164 | +0.5% | 0.00% | – |
Q2 2019 | $170,000 | +5566.7% | 16,081 | +4379.4% | 0.00% | – |
Q2 2017 | $3,000 | -25.0% | 359 | +10.1% | 0.00% | – |
Q1 2017 | $4,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +300.0% | 326 | +608.7% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | – | 46 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |